Condition: Prostate Cancer · Polygenic Risk Score · Sponsor: Adam S. Kibel, MD
The goal of this clinical trial is to evaluate a screening method to detect clinically relevant prostate cancer. This clinical trial is using genetic data to determine a man's risk of cancer, together with multiparametric magnetic resonance imaging (mpMRI) to identify men with higher grade cancer. The main questions it aims to answer are: * If genetic data related to prostate cancer used with MRI can identify higher-grade, potentially fatal prostate cancer * What age a MRI is useful clinically for prostate cancer screening * If deep learning methods used with MRI when the genetic risk of the man is known can more accurately predict significant cancers Participants will: * Get a prostate specific antigen (PSA) blood test * Get an mpMRI * Get the results of their genetic data to determine if they are considered high-, intermediate-, or low-risk for prostate cancer based on the trials genetic testing * Follow-up for this trial based on the participants risk and findings from the PSA test and mpMRI
This description comes directly from the study's public registry record.
Adam S Kibel, MD, MHCM · (617) 525-7697 · akibel@bwh.harvard.edu
Daniella Furtado · (617) 525-8782 · dfurtado1@bwh.harvard.edu
Always discuss trial participation with your own doctor first.
| Howard University Hospital | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| National Cancer Institute | Bethesda, Maryland, United States | Not Yet Recruiting |
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | Not Yet Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06398639